Skip to main content
OpenTrials

Clinical trial condition

Metal Metabolism, Inborn Errors

Explore clinical trials studying Metal Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

206 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Metal Metabolism, Inborn Errors trial results

Active, not recruiting

A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease

NCT04884815

Conditions
Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +16 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford University Redwood City, California, United States
  • University of California Davis Sacramento, California, United States
  • Northwestern University Chicago, Illinois, United States
View all 16 locations
View Trial Details
Active, not recruiting

Treatment of Hemochromatosis

NCT00007150

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hemochromatosis, +6 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Active, not recruiting

X-linked Hypophosphatemia Disease Monitoring Program

NCT03651505

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +27 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Rady Children's Hospital San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 38 locations
View Trial Details
Active, not recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details
Active, not recruiting

Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase Alfa

NCT06079281

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hypophosphatasia, +4 more
Locations
  • Research Site Indianapolis, Indiana, United States
  • Research Site Garden City, New York, United States
  • Research Site Durham, North Carolina, United States
  • Research Site Columbus, Ohio, United States
View all 65 locations
View Trial Details

Related conditions